Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Mineralys Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Acrivon Therapeutics Inc. June 13, 202592.1%
-
Mineralys Therapeutics Inc. May 22, 202585.6%
-
Werewolf Therapeutics Inc. June 21, 202378.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Acrivon Therapeutics Inc. | Grant or award | +9,366 | — | — |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Grant or award | +6,200 | — | — |
Questions about Derek DiRocco
What boards is Derek DiRocco on?
Derek DiRocco sits on the boards of Acrivon Therapeutics Inc., Evommune Inc., Mineralys Therapeutics Inc. and Werewolf Therapeutics Inc.
How long has Derek DiRocco served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.